These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10902616)

  • 1. Risk of fatal pulmonary embolism with oral contraceptives.
    Poulter NR
    Lancet; 2000 Jun; 355(9221):2088. PubMed ID: 10902616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and fatal pulmonary embolism.
    Parkin L; Skegg DC; Wilson M; Herbison GP; Paul C
    Lancet; 2000 Jun; 355(9221):2133-4. PubMed ID: 10902629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
    Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and venous thromboembolism: consensus conference statement.
    Dialogues in Contraception Consensus Conference (1995: Chicago)
    Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and venous thromboembolism: a five-year national case-control study.
    Lidegaard Ø; Edström B; Kreiner S
    Contraception; 2002 Mar; 65(3):187-96. PubMed ID: 11929640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
    Helmerhorst FM; Bloemenkamp KW; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1997 Jul; 78(1):327-33. PubMed ID: 9198174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M; Mann J; Murphy M; Vessey M
    Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential risk of oral contraceptives: the impact of full exposure history.
    Lewis MA; MacRae KD; Kühl-Habichl D; Bruppacher R; Heinemann LA; Spitzer WO
    Hum Reprod; 1999 Jun; 14(6):1493-9. PubMed ID: 10359554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
    Heinemann LA; Dinger JC; Assmann A; Minh TD
    Contraception; 2010 May; 81(5):401-7. PubMed ID: 20399946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
    Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
    Hedenmalm K; Samuelsson E; Spigset O
    Acta Obstet Gynecol Scand; 2004 Jun; 83(6):576-85. PubMed ID: 15144341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on the concept of "risk".
    Westhoff CL
    Dialogues Contracept; 1996; 5(1):8-9. PubMed ID: 12347723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
    Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
    N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and venous thromboembolism.
    Paul C
    N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec; 346(8990):1575-82. PubMed ID: 7500748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.